Chase Knickerbocker
Analyst/Questioner (Craig Hallam)
Replay available
Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Alice Nguye
Senior Vice President of Investor Relations and Corporate Communications
John Shannon
CEO
Jason Doerr
Analyst/Questioner (Oppenheimer)
Steve Piper
CFO
Mazir Alimond
Analyst/Questioner (Lee Ring Partners)
David Omselem
Analyst/Questioner (Piper Stendler)
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Xeris Biopharma Holdings, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.718 Good morning. Thank you for attending today's VAERS Bioforma first quarter 2025 results 00:00:05.718 -- 00:00:10.364 conference call. My name is Micaiah and I'll be the moderator for today's call. 00:00:10.364 -- 00:00:14.089 All lines will be muted in the presentation portion of the call with an opportunity for 00:00:14.089 -- 00:00:18.675 your questions and answers at the end. At this time, I'd like to pass the call over to 00:00:18.675 -- 00:00:23.220 our Senior Vice President of Investor Relations and Corporate Communications, Alice Nguye. 00:00:23.220 -- 00:00:26.001 Alice, you may proceed. 00:00:26.364 -- 00:00:28.735 Thank you, Micaiah. Good morning, everyone. 00:00:28.735 -- 00:00:31.098 We appreciate you joining our call this morning. 00:00:31.098 -- 00:00:35.564 Today, I'm joined by John Shannon, our CEO, and Steve Piper, our CFO. 00:00:35.564 -- 00:00:38.989 Earlier this morning, we issued a press release with our detailed results, which can 00:00:38.989 -- 00:00:44.256 be found on our website. After our prepared remarks, we will open the line for questions. 00:00:44.256 -- 00:00:48.582 Before we begin, I'd like to remind you that this call will contain forward-looking statements 00:00:48.582 -- 00:00:52.768 concerning the company's future expectations, plans, 00:00:52.768 -- 00:00:57.074 projects, and financial performance. Forward-looking statements are subject to risks 00:00:57.074 -- 00:01:02.191 and uncertainties. that could cause actual results to differ materially from those forward-looking 00:01:02.191 -- 00:01:07.178 statements. For more information on our risks, please refer to our earnings release and 00:01:07.178 -- 00:01:12.506 risk factors included in our SEC filing. Any forward-looking statements 00:01:12....